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A B S T R A C T
Medically refractory status epilepticus (RSE) causes high morbidity and mortality in children. There are
no evidence-based guidelines for treatment. Epilepsy surgery is a treatment option for RSE. We describe a
9-year-old boy treated successfully for RSE with complete corpus callosotomy (CC). Epilepsy surgery
should be considered for prolonged RSE. In the absence of evidence of focal epileptogenesis, complete
corpus callosotomy may be effective in select cases.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) is refractory to initial intravenous
therapy with lorazepam in about 30% of cases.1 Second and third
line therapy aborts SE in some, but those patients refractory to this
initial round of treatment, going on to pharmacologic coma
therapy, represent a signiﬁcant fraction and the major cause of
morbidity and mortality in SE. In adults persistent SE despite trials
of anesthesia for cerebral suppression is referred to as refractory or
‘‘malignant status epilepticus’’, and represents 20% of cases.2
Medically refractory status epilepticus (RSE) has a high morbidity
and mortality in children, estimated at 16–32%.3,4 Neurosurgical
intervention is a treatment option for RSE. We describe a case of a
9-year-old boy treated with complete corpus callosotomy (CC) to
abort an episode of recurrent RSE.
2. Case report
A 9-year-old Caucasian male with a history of medically
refractory epilepsy presented with altered mentation for 2 days.
Parents reported a viral syndrome with low-grade fever 5 days* Corresponding author at: Department of Pediatrics, Division of Child Neurology,
Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 2015,
Cincinnati, OH 45229, United States. Tel.: +1 513 636 4222; fax: +1 513 636 0018.
E-mail address: hansel.greiner@cchmc.org (H.M. Greiner).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2012.01.010before, but he had been afebrile for 3 days prior to admission.
Typically seizures occurred at baseline one to two times a night,
consisting of brief eye opening and tonic stiffening of both arms.
On presentation he was having more frequent clinical events, and
on examination showed signs of acute encephalopathy. Electro-
encephalogram (EEG) showed very frequent bursts of generalized
beta rhythms followed by slow waves, correlating with eye
opening and eyelid ﬂuttering on video (Fig. 1). This pattern evolved
into continuous rhythmic slow waves, consistent with SE.
The patient had a history of multiple seizure types beginning at
age three (myoclonic, tonic and drop seizures) and three prior
episodes of SE. One episode occurring 6 months prior to
presentation was refractory requiring pharmacologic coma. With
this prior episode, he presented with low-grade fever and upper
respiratory symptoms. There was a clustering of his typical tonic
seizures evolving to SE, refractory to intravenous benzodiazepines,
valproate and fosphenytoin. He was electively intubated and
treated for 4 days with pentobarbital for cerebral suppression. The
patient returned to his typical seizure frequency and was
discharged 2 weeks from admission. Upon review, there was no
history of febrile or hyperthermia-induced seizures, and no family
history of febrile seizures or epilepsy. Detailed neuropsychological
testing with the Wechsler Intelligence Scale for Children (WISC-IV)
revealed global difﬁculties in many indices preventing formal
score calculation. The perceptual reasoning (PRI) score was
extremely low at 55. Fine and gross motor skills were reportedly
normal.vier Ltd. All rights reserved.
Fig. 1. Standard 10-20 system EEG displayed in average referential montage. Frequent bursts of ictal beta rhythms, generalized but maximal in the bifrontal regions, were
observed. On close inspection of the video, this activity correlated with eye opening and eyelid ﬂuttering.
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Trials of intravenous benzodiazepines and valproate were
ineffective. On day two he was transferred to the intensive care
unit (ICU) for pharmacologic coma with intravenous midazolam.
Burst suppression was eventually achieved with high dose
continuous pentobarbital and ketamine. Over the next 30 days,
he cycled in and out of burst suppression four times, and developed
recurring SE with each attempted wean from pharmacologic coma.
Several anticonvulsant trials and the ketogenic diet were ineffec-
tive. Medical complications of his ICU stay included ventilator-
associated pneumonia and hemodynamic instability requiring
vasopressors.
The results of a previous presurgical workup were reviewed,
including prior video-EEG monitoring and structural and func-
tional imaging. Detailed 3-Tesla (3 T) magnetic resonance imaging
(MRI) had been negative for lesional cause. Fluorodeoxyglucose
positron emission tomography (FDG-PET) had shown subtle left
temporal and anterior parietal hypometabolism. Ictal single
photon emission computed tomography (SPECT) with subtraction
ictal SPECT co-registered to MRI (SISCOM) and previous scalp EEG
were not clearly lateralizing. After this workup, the family had
been offered the option of CC or bilateral strip electrode placement
to determine lateralization and subsequent possible resection, but
had postponed this decision. Based on available information at the
time of the most recent status epilepticus episode, our surgical
team concluded he was not a resective surgery candidate.
Therefore the option of complete CC to abort RSE and palliate
seizures was offered.
Two days prior to CC, the patient had breakthrough SE requiring
higher doses of ketamine and pentobarbital infusions. Immediately
preoperatively the EEG pattern was burst suppression. Intraopera-
tively, the pentobarbital infusion was continued. Neither electro-
corticography nor scalp EEG was performed intraoperatively, since
it is expected this would have demonstrated a burst suppression
pattern and added a slightly increased risk for morbidity. After the
procedure, he was monitored with limited scalp EEG electrodes.
The ketamine and pentobarbital were weaned over a period of 17
days without recurrence of SE. He was maintained on phenobar-
bital and valproate, which had been previously tried preoperatively.
After extubation and stabilization, he had a severe global
encephalopathy. A component of akinesis related to callosal
disconnection was suspected, but a speciﬁc disconnection syndromewas not identiﬁed. He received 5 weeks of inpatient rehabilitation.
On discharge he had evidence of moderate neurological insult
compared to prior baseline, including impaired frontal lobe function
and incoordination. He required gait assistance. Six months after
surgery, neurological function had recovered to baseline. At 12
month follow-up, seizure frequency was one to two per day, similar
to prior to admission; there had been no recurrences of SE.
4. Discussion
The beneﬁts of CC to prevent recurrence of SE have been
previously described.5 To our knowledge, this is the ﬁrst reported
case of successful surgical treatment of ongoing pediatric RSE with
CC alone: previous reports describe CC as part of a resective
procedure, such as hemispherectomy or focal resection with CC. In
our report, anticonvulsant medications which were ineffective
preoperatively were sufﬁcient to prevent relapse into RSE postop-
eratively while the same anesthetic agents were weaned. There are
only six case reports of successful disconnective or disruptive
epilepsy surgery (excluding hemispherectomy) for pediatric RSE.6,7
There is little evidence-based guidance for treating RSE.
Treatment strategies may follow from consideration of the
differential diagnosis—in our patient with a history of prior RSE,
an infectious or inﬂammation-mediated encephalopathy was
considered unlikely. Pharmacologic coma is often initiated, but
in some cases cerebral suppression proves ineffective when the
patient re-emerges from coma with SE. Ma et al. recommend
consideration of surgical treatment after failure of three trials of
pharmacologic coma therapy over 2 weeks.8 In the setting of focal
epilepsy, particularly with lesional ﬁndings on magnetic resonance
imaging (MRI), RSE is clearly amenable to focal resection or
hemispherectomy. In a retrospective study of 10 patients with
focal epileptogenesis, all were treated surgically, successfully
aborting RSE and without mortality.9 In our case, a prior
presurgical workup identiﬁed the patient as a poor resective
surgical candidate. Since resective surgery could not be accom-
plished, additional trials of anesthetic agents were attempted
before a palliative procedure was considered.
In the absence of a clear anatomical focus for seizures or in the
presence of signs suggestive of generalized epilepsy, resective
surgery is not an option. Disconnective or disruptive procedures,
including CC, multiple subpial transections, vagal nerve stimulation
(VNS) and electroconvulsive therapy may effectively abort RSE.
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the treatment of tonic seizures, the patient’s habitual seizure type.10
For this indication, the added beneﬁt of complete disconnection in
complete CC compared to anterior two-thirds sectioning may
outweigh the difference in surgical risk, as some reports demon-
strate lower relapse rate in tonic and drop seizures with complete
CC.11,12 Complete callosal section is associated with improved
seizure outcome in prepubescent children and children with global
cerebral dysfunction.13,14 Our patient’s young age and cognitive
impairment were factors favoring complete CC in clinical decision-
making. While the extent of callosal section correlates with the risk
for development of a disconnection syndrome, studies in prepubes-
cent children show that functional gain and family satisfaction post-
callosotomy are most strongly correlated with seizure control, not
extent of callosal section.13–15 The mechanism by which CC may
abort seizures, rather than simply prevent generalization, is unclear.
However, it is well-documented that CC can reduce partial seizures,
indicating that it may have some antiepileptic effect.16,17 Further,
presurgical evaluation after CC may identify a resectable focus in
some patients; favorable seizure outcome can be obtained from
subsequent surgery following CC.18,19
The limitations of the report include a lack of direct evidence
that CC was responsible for terminating the patient’s RSE. It is
possible that the natural history of the RSE episode was such that it
would have relented without surgical intervention. Since patients
with RSE are typically in a pharmacologic coma necessitated by the
diagnosis, it is not always practical to demonstrate direct evidence
of termination of RSE intraoperatively. The most common
anesthetic agent used is a barbiturate; even after discontinuation
barbiturates continue to cause cerebral suppression for several
hours. That the same medications tried ineffectually preoperative-
ly were sufﬁcient postoperatively, and that pharmacologic coma
was able to be discontinued, is indicative of the beneﬁt of CC to
terminate RSE in this case.
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